Ascent Wealth Partners LLC Sells 6,928 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Ascent Wealth Partners LLC cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 32.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 14,173 shares of the biotechnology company’s stock after selling 6,928 shares during the quarter. Axon Enterprise makes up 1.1% of Ascent Wealth Partners LLC’s portfolio, making the stock its 27th biggest position. Ascent Wealth Partners LLC’s holdings in Axon Enterprise were worth $8,423,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after acquiring an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP lifted its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC lifted its holdings in shares of Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment acquired a new position in Axon Enterprise in the third quarter valued at about $200,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 5.3 %

Axon Enterprise stock opened at $513.22 on Friday. The stock has a market capitalization of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.43 and a beta of 1.05. The business has a fifty day moving average price of $619.94 and a 200-day moving average price of $518.66. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 1-year low of $265.32 and a 1-year high of $715.99.

Analysts Set New Price Targets

A number of research analysts have issued reports on AXON shares. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. TD Cowen assumed coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Robert W. Baird boosted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Finally, JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $561.31.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the sale, the insider now owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 8,711 shares of company stock worth $5,631,561. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.